Cargando…
Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma
Clear cell sarcoma is an aggressive soft tissue sarcoma and highly resistant to conventional chemotherapy and radiation therapy. This devastating disease is defined by EWSR1‐ATF1 fusion gene resulting from chromosomal translocation t(12;22)(q13;q12) and characterized by melanocytic differentiation....
Autores principales: | Nakai, Takaaki, Imura, Yoshinori, Tamiya, Hironari, Yamada, Shutaro, Nakai, Sho, Yasuda, Naohiro, Kaneko, Keiko, Outani, Hidetatsu, Takenaka, Satoshi, Hamada, Kenichiro, Myoui, Akira, Araki, Nobuhito, Ueda, Takafumi, Itoh, Kazuyuki, Yoshikawa, Hideki, Naka, Norifumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603837/ https://www.ncbi.nlm.nih.gov/pubmed/28745431 http://dx.doi.org/10.1002/cam4.1130 |
Ejemplares similares
-
Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma
por: Yamada, Shutaro, et al.
Publicado: (2017) -
Functional and therapeutic relevance of hepatocyte growth factor/c‐MET signaling in synovial sarcoma
por: Imura, Yoshinori, et al.
Publicado: (2016) -
Author Correction: Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs
por: Nakai, Sho, et al.
Publicado: (2020) -
Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs
por: Nakai, Sho, et al.
Publicado: (2019) -
Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma
por: Imura, Yoshinori, et al.
Publicado: (2014)